EUVIMEDEUVIMED entdecken
Fallbericht

Thyroblastoma in a Pediatric Patient: A Case Report Highlighting Diagnostic Pitfalls and Management Challenges

Ahmed Hassan Mohamed, Mahmoud Abdelaziz, Sara Elsaeed, Mena Mahfouz, Rokia Masoud Salama, Ekbal Elkhouli, Khaled Mamdouh Bonna

SN Comprehensive Clinical Medicine · 09.09.2026 · 8 (1)

DOI: 10.1007/s42399-026-02632-0 ↗

Kurz gefasst

Fallbericht in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 09.09.2026. Verfasst von Ahmed Hassan Mohamed und 6 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thyroblastoma is a rare, aggressive thyroid neoplasm newly classified in the 2022 WHO Classification of Endocrine Tumors, predominantly reported in adults, characterized by embryonal, multilineage morphology and is characterized by DICER1 mutations. Fewer than 15 well-characterized cases have been reported, with limited cytological descriptions. What is unique about this case is that it documents thyroblastoma in a 13-year-old female potentially the youngest reported patient and demonstrates the critical diagnostic pitfall of false-negative FNAC leading to inadequate initial surgery. This case adds to the literature by expanding the known age range and emphasizing the unreliability of cytology for this entity. Main Symptoms and Clinical Findings A 13-year-old female presented with a right-sided neck mass. Ultrasound revealed a 4.6 × 2.7 cm mixed solid-cystic nodule (TIRADS 4). The patient was asymptomatic otherwise, with no relevant medical or family history. Diagnoses, Interventions, and Outcomes Preoperative FNAC was interpreted as benign colloid nodule (Bethesda II), leading to right hemithyroidectomy. Histopathology unexpectedly revealed a biphasic malignant tumor. Immunohistochemistry (TTF-1/PAX8 + epithelium; SALL4/SMA/Desmin+ stroma) confirmed thyroblastoma. Completion total thyroidectomy and right lateral neck dissection identified lymphovascular invasion and metastatic disease in 3 of 13 lymph nodes. The patient was initiated on BEP chemotherapy (bleomycin, etoposide, cisplatin).

Conclusion

This case highlights that FNAC is unreliable for diagnosing thyroblastoma and can lead to insufficient initial surgery. Radical resection is required. Thyroblastoma should be included in the differential diagnosis of pediatric thyroid cancers, and a high index of suspicion is necessary when cytology appears benign but clinical features are concerning.

Zitieren

APA

Mohamed, A. H., Abdelaziz, M., Elsaeed, S., Mahfouz, M., Salama, R. M., Elkhouli, E., & Bonna, K. M. (2026). Thyroblastoma in a Pediatric Patient: A Case Report Highlighting Diagnostic Pitfalls and Management Challenges. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02632-0

Vancouver

Mohamed AH, Abdelaziz M, Elsaeed S, Mahfouz M, Salama RM, Elkhouli E, et al. Thyroblastoma in a Pediatric Patient: A Case Report Highlighting Diagnostic Pitfalls and Management Challenges. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02632-0

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Ahmed Hassan and Abdelaziz, Mahmoud and Elsaeed, Sara and Mahfouz, Mena and Salama, Rokia Masoud and Elkhouli, Ekbal and Bonna, Khaled Mamdouh},
  title = {Thyroblastoma in a Pediatric Patient: A Case Report Highlighting Diagnostic Pitfalls and Management Challenges},
  journal = {SN Comprehensive Clinical Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1007/s42399-026-02632-0}
}
Kostenlos starten →